Developer docs
API playgroundTry for free, no card

Search company profiles

Steps Biosciences

Full company profile

uuid000cpr8

Namestring
Steps Biosciences
Legal namestring
Steps Biosciences, Inc
Websiteurl
stepsbio.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Steps Biosciences is a virtual sterile product development company incorporated in Delaware, USA in September 2018, with operational headquarters in Bengaluru, India via its wholly-owned subsidiary Steps Bio India Pvt Ltd. The company develops complex small-molecule sterile products under two regulatory pathways — generic equivalents (ANDA) and differentiated formulations (505(b)(2)) — for both human and veterinary applications, with a portfolio spanning depot/long-acting injectables, nano-formulations (nano-emulsions and nano-suspensions), controlled-substance sterile products, high-containment products (oncology, steroids, hormones, antibiotics), and conventional injectable and ophthalmic sterile dosage forms.

Rather than operating its own manufacturing facilities, Steps Bio executes development through a global network of contract research and contract manufacturing organizations (CROs/CMOs), which keeps capex requirements low and allows flexible scaling. Its revenue model combines co-development partnerships (shared costs and IP with development-fee and milestone revenue) with out-licensing of developed sterile product portfolios (upfront payments, milestones, and royalties) directed at pharmaceutical companies, biotechnology firms, academic and research institutions, and veterinary pharmaceutical companies.

The leadership and advisory bench is the company's most differentiated asset: co-founders include the former COO of Syngene International (Manoj Nerurkar) and the former SVP and head of injectable R&D at Dr. Reddy's Laboratories (Harshal Bhagwatwar, who led development of 30+ sterile products), supported by a CFO and CCO with Big Pharma/generics backgrounds and advisors including the former VP/Global Head of Pharmaceutical R&D at Bayer. In June 2026, Steps Bio established a Centre of Excellence (GSRC) with GV Research Platform (GVRP) inside Bengaluru's 1BLR Life Sciences Cluster to anchor its formulations R&D footprint in India's life-sciences ecosystem.

Short descriptiontext

Steps Biosciences is a virtual sterile product development company developing generic equivalents (ANDA) and differentiated formulations (505(b)(2)) — including depot, nano-formulation, controlled-substance, and containment sterile products — for pharmaceutical, biotech, academic, and veterinary clients via co-development partnerships and out-licensing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSaint Georges, United States
HQ citystring
Saint Georges
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sterile product development, complex generic injectables, pharmaceutical co-development, differentiated sterile formulations, 505(b)(2) drug development
Industry1 code
PRIMARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)
NAICS code4 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Commercial Physical & Biological Research8731
Product category
Sterile Pharmaceutical Product Development
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Co-development Partnerships
TypeProfessional Services
Description

Joint development of sterile products with pharmaceutical partners where costs and intellectual property are shared, generating revenue through development fees and milestone payments.

stepsbio.com
2Product Out-licensing
TypeLicensing Royalties
Description

Licensing of developed sterile product portfolios to pharmaceutical companies for commercialization, generating revenue through upfront payments, milestone payments, and royalties.

stepsbio.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Steps Biosciences is a sterile product development company that develops complex generic equivalents (ANDA) and differentiated formulations (505(b)(2)) for human and veterinary applications. Operating as a virtual organization, it leverages a global partner network of CROs and CMOs to deliver depot formulations, nano-formulations, controlled substance sterile products, high-containment products, and conventional injectables and ophthalmics through co-development partnerships and out-licensing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Steps Biosciences is a small molecule, sterile product development company developing both generic equivalents (ANDA) and differentiated formulations (505(b)(2)) to solve unmet medical needs. The company operates as a virtual organization leveraging a global partner network of CROs and CMOs. Its portfolio spans multiple sterile dosage form categories: depot formulations, controlled substance products, nano-formulations (nano-emulsions and nano-suspensions), containment products for oncology/steroids/hormones/antibiotics, and conventional injectable and ophthalmic products. Steps Biosciences supports both human and veterinary applications.

Product and service5 records
1Co-development partnerships for sterile products
CategoryCo-development services
2Out-licensing of sterile products portfolio
CategoryLicensing
3Generic equivalents (ANDA) sterile products
CategorySterile generic product development
4Differentiated formulations (505(b)(2)) sterile products
CategorySterile differentiated product development
5Veterinary sterile products
CategoryVeterinary sterile product development
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-06
Description

Hyderabad-based GV Research Platform (GVRP) and Bengaluru-based Steps Biosciences partnered to establish a Centre of Excellence (CoE) for formulations research and development, named GSRC, located within the Lifescapes campus at the 1BLR Life Sciences Cluster in Bengaluru. The facility aims to advance pharmaceutical formulations R&D, support complex drug development programmes, and foster collaboration among pharmaceutical companies, biotech firms, researchers, and academic institutions. The launch reinforces Bengaluru's position as a leading life sciences hub and strengthens India's capabilities in the global pharmaceutical and formulation research sector.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based CDMO specializing in sterile injectable development and manufacturing for pharma and biotech. Directly comparable as a contract development organization focused on complex sterile dosage forms serving similar pharmaceutical and biotech customers.

2Pharmaceutics International Inc (Pii)
TypeDirect peer
Description

Sterile injectable development and manufacturing CDMO with capabilities in complex formulations and aseptic fill-finish. Comparable as a specialized sterile injectables CDMO serving similar pharma and biotech partner base with development and manufacturing services.

TypeDirect peer
Description

India-based injectable-focused pharmaceutical company with strong sterile injectables portfolio and CDMO capabilities. Comparable as a sterile injectables specialist with co-development and licensing business model serving global pharma partners.

TypeDirect peer
Description

Specialty pharmaceutical company focused on injectable and inhalation products with complex formulation capabilities. Comparable as a sterile injectables specialist pursuing generic and differentiated formulations with limited internal manufacturing.

TypeBroad incumbent
Description

Global pharmaceutical company with major sterile injectable franchise including specialty and complex generics. Comparable as a broad incumbent with deep sterile injectables portfolio pursuing both generic (ANDA) and differentiated formulations across multiple therapeutic areas.

TypeBroad incumbent
Description

Large global CDMO with extensive sterile injectable development and manufacturing capabilities. Comparable as a broad incumbent offering end-to-end sterile drug product development services to pharma and biotech, though operating at significantly larger scale.

7Syngene International
TypeDirect peer
Description

India-based CRO/CDMO offering integrated discovery, development, and manufacturing services to global pharma. Comparable given Steps Bio co-founder Manoj Nerurkar served as Syngene's COO; both serve pharmaceutical and biotech clients with formulation and development services from India.

8Recipharm
TypeBroad incumbent
Description

European CDMO with sterile injectable fill-finish and development capabilities. Comparable as a broad CDMO incumbent offering sterile drug product development services to global pharma partners, including complex generics.

9Endo International (Sterile Injectables)
TypeBroad incumbent
Description

Specialty pharmaceutical company with significant sterile injectable franchise including generics and proprietary products. Comparable as a broad incumbent in complex sterile injectables with both development and commercialization capabilities.

TypeRegional player
Description

India-based CRO/CDMO offering drug discovery, development, and manufacturing services to global pharma and biotech. Comparable as an India-based peer offering formulation and development services in the same regional ecosystem, though with broader discovery focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Steps Biosciences

Sterile Pharmaceutical Product Developmentstepsbio.com

Steps Biosciences is a virtual sterile product development company developing generic equivalents (ANDA) and differentiated formulations (505(b)(2)) — including depot, nano-formulation, controlled-substance, and containment sterile products — for pharmaceutical, biotech, academic, and veterinary clients via co-development partnerships and out-licensing.

What Steps Biosciences does

Steps Biosciences is a virtual sterile product development company incorporated in Delaware, USA in September 2018, with operational headquarters in Bengaluru, India via its wholly-owned subsidiary Steps Bio India Pvt Ltd. The company develops complex small-molecule sterile products under two regulatory pathways — generic equivalents (ANDA) and differentiated formulations (505(b)(2)) — for both human and veterinary applications, with a portfolio spanning depot/long-acting injectables, nano-formulations (nano-emulsions and nano-suspensions), controlled-substance sterile products, high-containment products (oncology, steroids, hormones, antibiotics), and conventional injectable and ophthalmic sterile dosage forms.

Rather than operating its own manufacturing facilities, Steps Bio executes development through a global network of contract research and contract manufacturing organizations (CROs/CMOs), which keeps capex requirements low and allows flexible scaling. Its revenue model combines co-development partnerships (shared costs and IP with development-fee and milestone revenue) with out-licensing of developed sterile product portfolios (upfront payments, milestones, and royalties) directed at pharmaceutical companies, biotechnology firms, academic and research institutions, and veterinary pharmaceutical companies.

The leadership and advisory bench is the company's most differentiated asset: co-founders include the former COO of Syngene International (Manoj Nerurkar) and the former SVP and head of injectable R&D at Dr. Reddy's Laboratories (Harshal Bhagwatwar, who led development of 30+ sterile products), supported by a CFO and CCO with Big Pharma/generics backgrounds and advisors including the former VP/Global Head of Pharmaceutical R&D at Bayer. In June 2026, Steps Bio established a Centre of Excellence (GSRC) with GV Research Platform (GVRP) inside Bengaluru's 1BLR Life Sciences Cluster to anchor its formulations R&D footprint in India's life-sciences ecosystem.

Steps Biosciences firmographics

Firmographics
Name
Steps Biosciences
Legal name
Steps Biosciences, Inc
Website
https://stepsbio.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Steps Biosciences is a virtual sterile product development company developing generic equivalents (ANDA) and differentiated formulations (505(b)(2)) — including depot, nano-formulation, controlled-substance, and containment sterile products — for pharmaceutical, biotech, academic, and veterinary clients via co-development partnerships and out-licensing.
Ownership category
akta.pro rank

Steps Biosciences industry classification

Industry
Product category
Sterile Pharmaceutical Product Development
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAKAF
Process Development & Tech Transfer Services (upstream/downstream)

Keywords

  • Sterile product development
  • Complex generic injectables
  • Pharmaceutical co-development
  • Differentiated sterile formulations
  • 505(b)(2) drug development

Where Steps Biosciences is headquartered

Location

Headquarters

HQ city
Saint Georges
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Steps Biosciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Co-development Partnerships: Joint development of sterile products with pharmaceutical partners where costs and intellectual property are shared, generating revenue through development fees and milestone payments.
  2. Product Out-licensing: Licensing of developed sterile product portfolios to pharmaceutical companies for commercialization, generating revenue through upfront payments, milestone payments, and royalties.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Steps Biosciences product offering

Product offering

Core offering

Steps Biosciences is a sterile product development company that develops complex generic equivalents (ANDA) and differentiated formulations (505(b)(2)) for human and veterinary applications. Operating as a virtual organization, it leverages a global partner network of CROs and CMOs to deliver depot formulations, nano-formulations, controlled substance sterile products, high-containment products, and conventional injectables and ophthalmics through co-development partnerships and out-licensing.

Product overview

Steps Biosciences is a small molecule, sterile product development company developing both generic equivalents (ANDA) and differentiated formulations (505(b)(2)) to solve unmet medical needs. The company operates as a virtual organization leveraging a global partner network of CROs and CMOs. Its portfolio spans multiple sterile dosage form categories: depot formulations, controlled substance products, nano-formulations (nano-emulsions and nano-suspensions), containment products for oncology/steroids/hormones/antibiotics, and conventional injectable and ophthalmic products. Steps Biosciences supports both human and veterinary applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Co-development partnerships for sterile products
  • Out-licensing of sterile products portfolio
  • Generic equivalents (ANDA) sterile products
  • Differentiated formulations (505(b)(2)) sterile products
  • Veterinary sterile products

Companies that use Steps Biosciences

Customer profile

Segments4 records

Ideal customer profiles4 records

Steps Biosciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Steps Biosciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • GV Research Platform (GVRP)coreStrategic or Co-development Partner · 6 June 2026Hyderabad-based GV Research Platform (GVRP) and Bengaluru-based Steps Biosciences partnered to establish a Centre of Excellence (CoE) for formulations research and development, named GSRC, located within the Lifescapes campus at the 1BLR Life Sciences Cluster in Bengaluru. The facility aims to advance pharmaceutical formulations R&D, support complex drug development programmes, and foster collaboration among pharmaceutical companies, biotech firms, researchers, and academic institutions. The launch reinforces Bengaluru's position as a leading life sciences hub and strengthens India's capabilities in the global pharmaceutical and formulation research sector.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Steps Biosciences competitors and assessment

Company assessment

Direct peers

  • Alcami Corporation: US-based CDMO specializing in sterile injectable development and manufacturing for pharma and biotech. Directly comparable as a contract development organization focused on complex sterile dosage forms serving similar pharmaceutical and biotech customers.
  • Pharmaceutics International Inc (Pii): Sterile injectable development and manufacturing CDMO with capabilities in complex formulations and aseptic fill-finish. Comparable as a specialized sterile injectables CDMO serving similar pharma and biotech partner base with development and manufacturing services.
  • Gland Pharma: India-based injectable-focused pharmaceutical company with strong sterile injectables portfolio and CDMO capabilities. Comparable as a sterile injectables specialist with co-development and licensing business model serving global pharma partners.
  • Amphastar Pharmaceuticals: Specialty pharmaceutical company focused on injectable and inhalation products with complex formulation capabilities. Comparable as a sterile injectables specialist pursuing generic and differentiated formulations with limited internal manufacturing.
  • Syngene International: India-based CRO/CDMO offering integrated discovery, development, and manufacturing services to global pharma. Comparable given Steps Bio co-founder Manoj Nerurkar served as Syngene's COO; both serve pharmaceutical and biotech clients with formulation and development services from India.

Broad incumbents

  • Hikma Pharmaceuticals: Global pharmaceutical company with major sterile injectable franchise including specialty and complex generics. Comparable as a broad incumbent with deep sterile injectables portfolio pursuing both generic (ANDA) and differentiated formulations across multiple therapeutic areas.
  • Catalent: Large global CDMO with extensive sterile injectable development and manufacturing capabilities. Comparable as a broad incumbent offering end-to-end sterile drug product development services to pharma and biotech, though operating at significantly larger scale.
  • Recipharm: European CDMO with sterile injectable fill-finish and development capabilities. Comparable as a broad CDMO incumbent offering sterile drug product development services to global pharma partners, including complex generics.
  • Endo International (Sterile Injectables): Specialty pharmaceutical company with significant sterile injectable franchise including generics and proprietary products. Comparable as a broad incumbent in complex sterile injectables with both development and commercialization capabilities.

Regional players

  • Sai Life Sciences: India-based CRO/CDMO offering drug discovery, development, and manufacturing services to global pharma and biotech. Comparable as an India-based peer offering formulation and development services in the same regional ecosystem, though with broader discovery focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Steps Biosciences social profiles

Digital presence

Steps Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Steps Biosciences leadership team

Management profile

Number of profiles

Profiles8 records

Steps Biosciences subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Steps Biosciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Steps Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Steps Biosciences

What does Steps Biosciences do?

Steps Biosciences is a sterile product development company that develops complex generic equivalents (ANDA) and differentiated formulations (505(b)(2)) for human and veterinary applications. Operating as a virtual organization, it leverages a global partner network of CROs and CMOs to deliver depot formulations, nano-formulations, controlled substance sterile products, high-containment products, and conventional injectables and ophthalmics through co-development partnerships and out-licensing.

Is Steps Biosciences a public or private company?

Steps Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Steps Biosciences founded?

Steps Biosciences was founded in 2018. It employs 1 to 10 people.

Where is Steps Biosciences based?

Steps Biosciences is headquartered in Saint Georges, United States, in the North America region.

How does Steps Biosciences make money?

Two revenue lines are on record. Co-development Partnerships are the primary driver. The others are product Out-licensing.

Who are Steps Biosciences's main competitors?

Direct peers on record are Alcami Corporation, Pharmaceutics International Inc (Pii), Gland Pharma, Amphastar Pharmaceuticals and Syngene International. Broad incumbents are Hikma Pharmaceuticals, Catalent, Recipharm and Endo International (Sterile Injectables). Sai Life Sciences is listed as a regional player.

Does Steps Biosciences have an API?

No public API is recorded for Steps Biosciences.

What industry is Steps Biosciences in?

Steps Biosciences's product category is Sterile Pharmaceutical Product Development. Its primary akta.pro industry code is HLAAAKAF, Process Development & Tech Transfer Services (upstream/downstream). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ChemindigestGVRP and StepsBio Launch Centre of Excellence for Drug Formulation R&DHyderabad-based GV Research Platform (GVRP) and Bengaluru-based Steps Biosciences have partnered to establish a Centre of Excellence (CoE) for formulations research and development, named GSRC, located within the Lifescapes campus at the 1BLR Life Sciences Cluster in Bengaluru. The facility aims to advance pharmaceutical formulations R&D, support complex drug development programmes, and foster collaboration among pharmaceutical companies, biotech firms, researchers, and academic institutions. The launch reinforces Bengaluru's position as a leading life sciences hub and strengthens India's capabilities in the global pharmaceutical and formulation research sector.BusinessLineGVRP, StepsBio set up CoE for formulations R&D in BengaluruGV Research Platform (GVRP), a Hyderabad-based research organization, and Bengaluru-based Steps Biosciences have jointly established a Center of Excellence called GSRC for formulations research and development within the Lifescapes life sciences cluster in Bengaluru. The facility is purpose-built to address complex formulation challenges including drug delivery systems, sterile injectables, and differentiated dosage forms. The CoE represents GVRP's strategic expansion into high-complexity formulations and positions Bengaluru as a growing hub for life sciences innovation.Deccan ChronicleGVRP, StepsBio Launch GSRCGVRP and Steps Biosciences launched the GVRP StepsBio Research Centre (GSRC) in Bengaluru's Lifescapes cluster. The 15,000 sq ft facility supports drug delivery systems, sterile injectables, and dosage forms, with AI capabilities for formulation design and stability modeling.